Article Details
Retrieved on: 2021-01-05 09:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca has completed the divestment of the rights to its heart failure and hypertension brand Atacand (candesartan cilexetil) in Europe to ...
Article found on: www.pharmatimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here